Page 150 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 150
Cirrhosis and its Complications: Clinical Aspects (Cont.)
YI P0168 THE IMPACT ON HOSPITAL RESOURCE UTILISATION OF
RIFAXIMIN-ALPHA FOR HEPATIC ENCEPHALOPATHY IN
ROUTINE CLINICAL PRACTICE: REAL WORLD DATA FROM
SEVEN UK LIVER CENTRES
James G. Orr*, Anurag Goel, Kieran Moriarty, Ashish Sinha,
Fiona H. Gordon, Anne Dethier, John Dillon, Vishal Patel,
Debbie L. Shawcross, Katie Clark, Paul Richardson, Helen Preedy,
Richard Aspinall, Craig J. Currie, Mark Hudson, The United Kingdom
YI P0169 CRITICAL FLICKER FREQUENCY PREDICTS SURVIVAL IN
PATIENTS WITH LIVER CIRRHOSIS
Javier Ampuero*, Macarena Simón, Carmina Montoliú, Rodrigo Jover,
Miguel Ángel Serra, Juan Córdoba, Manuel Romero-Gómez, Spain
YI P0170 EFFECTS OF NUTRITIONAL THERAPY ON COGNITIVE
FUNCTIONS AND HEALTH RELATED QUALITY OF LIFE IN
ePOSTERS PATIENTS OF LIVER CIRRHOSIS WITH MINIMAL HEPATIC
ENCEPHALOPATHY- AN OPEN LABEL RANDOMIZED
CONTROLLED TRIAL
Sudhir Maharshi*, Barjesh Chander Sharma, Siddharth Srivastava, India
YI P0171 INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH
CIRRHOSIS – SUBANALYSIS OF THE FUNGAL INFECTION
RISK EVALUATION (FIRE) STUDY
Eleni Theocharidou*, Banwari Agarwal, Gary Jeffrey, Rajiv Jalan,
David Harrison, Andrew Burroughs, Christopher Kibbler,
The United Kingdom
YI P0172 PROTON PUMP INHIBITORS INCREASE THE RISK FOR
HEPATIC ENCEPHALOPATHY IN CIRRHOSIS
Gitte Dam*, Hendrik Vilstrup, Hugh Watson, Peter Jepsen, Denmark
YI P0173 PREDICTORS OF MORTALITY IN CIRRHOTIC PATIENTS
ADMITTED TO INTENSIVE CARE UNIT: COMPARISON OF
DIFFERENT SCORING SYSTEMS INCLUDING THE NEW
ROYAL FREE HOSPITAL SCORE
Niyada Naksuk, Thoetchai Peeraphatdit*, Charat Thongprayoon,
Lewis R. Roberts, Roongruedee Chaiteerakij, The United States
150 The International Liver Congress™ 2015 • ILC Programme
YI P0168 THE IMPACT ON HOSPITAL RESOURCE UTILISATION OF
RIFAXIMIN-ALPHA FOR HEPATIC ENCEPHALOPATHY IN
ROUTINE CLINICAL PRACTICE: REAL WORLD DATA FROM
SEVEN UK LIVER CENTRES
James G. Orr*, Anurag Goel, Kieran Moriarty, Ashish Sinha,
Fiona H. Gordon, Anne Dethier, John Dillon, Vishal Patel,
Debbie L. Shawcross, Katie Clark, Paul Richardson, Helen Preedy,
Richard Aspinall, Craig J. Currie, Mark Hudson, The United Kingdom
YI P0169 CRITICAL FLICKER FREQUENCY PREDICTS SURVIVAL IN
PATIENTS WITH LIVER CIRRHOSIS
Javier Ampuero*, Macarena Simón, Carmina Montoliú, Rodrigo Jover,
Miguel Ángel Serra, Juan Córdoba, Manuel Romero-Gómez, Spain
YI P0170 EFFECTS OF NUTRITIONAL THERAPY ON COGNITIVE
FUNCTIONS AND HEALTH RELATED QUALITY OF LIFE IN
ePOSTERS PATIENTS OF LIVER CIRRHOSIS WITH MINIMAL HEPATIC
ENCEPHALOPATHY- AN OPEN LABEL RANDOMIZED
CONTROLLED TRIAL
Sudhir Maharshi*, Barjesh Chander Sharma, Siddharth Srivastava, India
YI P0171 INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH
CIRRHOSIS – SUBANALYSIS OF THE FUNGAL INFECTION
RISK EVALUATION (FIRE) STUDY
Eleni Theocharidou*, Banwari Agarwal, Gary Jeffrey, Rajiv Jalan,
David Harrison, Andrew Burroughs, Christopher Kibbler,
The United Kingdom
YI P0172 PROTON PUMP INHIBITORS INCREASE THE RISK FOR
HEPATIC ENCEPHALOPATHY IN CIRRHOSIS
Gitte Dam*, Hendrik Vilstrup, Hugh Watson, Peter Jepsen, Denmark
YI P0173 PREDICTORS OF MORTALITY IN CIRRHOTIC PATIENTS
ADMITTED TO INTENSIVE CARE UNIT: COMPARISON OF
DIFFERENT SCORING SYSTEMS INCLUDING THE NEW
ROYAL FREE HOSPITAL SCORE
Niyada Naksuk, Thoetchai Peeraphatdit*, Charat Thongprayoon,
Lewis R. Roberts, Roongruedee Chaiteerakij, The United States
150 The International Liver Congress™ 2015 • ILC Programme
